ATE511836T1 - Verfahren zur unterdrückung von durch uv-licht induzierter hautcarcinogenese - Google Patents

Verfahren zur unterdrückung von durch uv-licht induzierter hautcarcinogenese

Info

Publication number
ATE511836T1
ATE511836T1 AT06758668T AT06758668T ATE511836T1 AT E511836 T1 ATE511836 T1 AT E511836T1 AT 06758668 T AT06758668 T AT 06758668T AT 06758668 T AT06758668 T AT 06758668T AT E511836 T1 ATE511836 T1 AT E511836T1
Authority
AT
Austria
Prior art keywords
light
skin carcinogenesis
suppressing skin
isothiocyanate
induced
Prior art date
Application number
AT06758668T
Other languages
English (en)
Inventor
Paul Talalay
Albena T Dinkova-Kostova
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of ATE511836T1 publication Critical patent/ATE511836T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06758668T 2005-04-29 2006-04-27 Verfahren zur unterdrückung von durch uv-licht induzierter hautcarcinogenese ATE511836T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67584705P 2005-04-29 2005-04-29
US75034105P 2005-12-15 2005-12-15
PCT/US2006/016012 WO2006118941A1 (en) 2005-04-29 2006-04-27 Methods of supressing uv light-induced skin carcinogenesis

Publications (1)

Publication Number Publication Date
ATE511836T1 true ATE511836T1 (de) 2011-06-15

Family

ID=36722066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06758668T ATE511836T1 (de) 2005-04-29 2006-04-27 Verfahren zur unterdrückung von durch uv-licht induzierter hautcarcinogenese

Country Status (12)

Country Link
US (1) US20090247477A1 (de)
EP (1) EP1890683B1 (de)
JP (1) JP2008539261A (de)
KR (1) KR20080045083A (de)
CN (1) CN101208079B (de)
AT (1) ATE511836T1 (de)
AU (1) AU2006242528B2 (de)
CA (1) CA2606382C (de)
IL (1) IL186960A0 (de)
MX (1) MX2007013396A (de)
NZ (1) NZ563852A (de)
WO (1) WO2006118941A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470583C (en) * 2001-12-18 2011-03-15 Xiangqun Gao Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
JP2011500680A (ja) * 2007-10-16 2011-01-06 ジョンズ・ホプキンス・ユニヴァーシティ 放射線傷害から皮膚を保護する方法
WO2010059245A2 (en) * 2008-11-21 2010-05-27 The Johns Hopkins University Compositions and methods for treating or preventing radiation injury
EP2229824A1 (de) 2009-03-12 2010-09-22 Nestec S.A. Kovalente Milchprotein/isothiocyanatkomplexe
DE102009058325A1 (de) * 2009-12-15 2011-06-16 Henning Vollert Brassica Extrakte zur Erhöhung des antioxidativen Potentials der Haut
WO2012037193A2 (en) 2010-09-17 2012-03-22 Brassica Protection Products Llc Formulations for treatment with glucosinolate
EP2709612A4 (de) * 2011-05-19 2015-07-01 Glax L L C Zusammensetzungen und verfahren zur behandlung und prävention von krebs durch targeting und inhibition von krebsstammzellen
CA2877338C (en) * 2012-07-05 2022-10-11 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
CA2904865A1 (en) * 2013-03-15 2014-10-16 Nutramax Laboratories, Inc. Sulforaphane/sulforaphane precursor and phytosterol/phytostanol compositions
KR101515573B1 (ko) * 2014-11-07 2015-04-28 주식회사 파미니티 뉴그린 추출물을 유효성분으로 함유하는 해독용 조성물
WO2018004901A1 (en) * 2016-07-01 2018-01-04 Access Business Group International Llc Compositions including bauhinia, methods of making and using the same in skin anti-aging and other skin applications
US20200179404A1 (en) * 2017-06-09 2020-06-11 Regents Of The University Of Minnesota Skin care formulations and skin cancer treatment
CN109588698A (zh) * 2017-09-30 2019-04-09 华中科技大学 一种防治酒精中毒性精神障碍的功能性食品和药品及其制法
CN110585049A (zh) * 2019-10-22 2019-12-20 赣州华汉生物科技有限公司 一种萝卜硫素防晒霜

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) * 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
EP1239826A2 (de) * 1999-12-20 2002-09-18 Cognis France S.A. Kosmetische und/oder pharmazeutische zubereitungen
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
AU2003263988A1 (en) * 2002-08-05 2004-02-23 Wackvom, Ltd. Methods and compositions to treat conditions associated with neovascularization
DE10308298A1 (de) * 2003-02-26 2004-09-09 Kullmer, Thomas, Priv. Doz. Dr. med. Verfahren zur Herstellung von Präparationen mit hochkonzentrierten Brassica-Inhaltsstoffen und deren Verwendung

Also Published As

Publication number Publication date
IL186960A0 (en) 2008-02-09
NZ563852A (en) 2011-07-29
US20090247477A1 (en) 2009-10-01
CA2606382A1 (en) 2006-11-09
EP1890683A1 (de) 2008-02-27
MX2007013396A (es) 2008-03-14
CN101208079B (zh) 2012-07-04
KR20080045083A (ko) 2008-05-22
CA2606382C (en) 2014-10-07
JP2008539261A (ja) 2008-11-13
AU2006242528A1 (en) 2006-11-09
EP1890683B1 (de) 2011-06-08
CN101208079A (zh) 2008-06-25
AU2006242528B2 (en) 2012-09-20
WO2006118941A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
ATE511836T1 (de) Verfahren zur unterdrückung von durch uv-licht induzierter hautcarcinogenese
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
BR112014026056A2 (pt) compostos, kits e métodos de biofotônica
AR054094A1 (es) Tratamientos de cancer
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
GT200600115A (es) Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal
ATE552000T1 (de) Verwendung von isothiocyanat-verbindungen zur behandlung von prostata-erkrankungen und hautkrebs
BRPI0513866A (pt) composição, micropartìculas, método para o tratamento da hipertensão pulmonar, e dispositivo de inalação
CL2015000148A1 (es) Inmunoglobulina g variante porque comprende dos o mas sustituciones de aminoácidos; composición farmacéutica y kit que comprenden dicha inmunolobulina; uso de dicha inmunoglobulina para tratar tumor
UA99101C2 (ru) Композиция для местного ухода за кожей, содержащая соединения глицерина ди- и моносалицилата
CY1109551T1 (el) Πρωτεασωμικοι αναστολεις και μεθοδοι χρησιμοποιησης αυτων
ATE513550T1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
BRPI0412815A (pt) extrato de plantas com eficácia prebiótica
ATE408412T1 (de) Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration
EA200900819A1 (ru) Хиназолины для ингибирования pdk1
DK1761266T3 (da) Forbindelser, formuleringer og fremgangsmåder til at behandle eller forebygge inflammatoriske hudsygdomme
NO20075849L (no) Fremgangsmater og preparater til behandling eller forebygging av kreft
CO2022003582A2 (es) Métodos para el tratamiento de la oftalmopatía tiroidea
ATE422873T1 (de) Kosmetische bzw. dermatologische präparate mit wirksamem lichtschutz
DE60224427D1 (de) Von einem polyamid stukturiertes mittel das einen n-acylierten ester einer aminosäure und einen uv-filter enthält
BRPI0902603A8 (pt) uso cosmético de pelo menos um composto ditiolano, composto ditiolano, composição e processo cosmético de preparação da pele para o sol
RU2015112839A (ru) Составы, содержащие идебенон, n-ацетил-s-фарнезил-l-цистеин и эрготионеин, и их применение
MX2020013730A (es) Metodo para tratar el cancer mediante la combinacion de un inhibidor de iap y un modulador de una molecula de punto de control inmunitario.
EA200801296A1 (ru) Способ лечения метаболического синдрома
ATE530163T1 (de) Verwendung von zubereitungen mit einem gehalt an hydroxycitrat und carnitin als wirksame prinzipien zur sebumreduktion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties